FOI Clinical Issue 9
Measles slows in some states. Reports on sexually transmitted shigellosis and flea-borne typhus.
I’m an epidemiologist and associate professor at Johns Hopkins, where I direct the Center for Outbreak Response Innovation. I have a PhD and an MPH. My book, Crisis Averted: The Hidden Science of Fighting Outbreaks was published by Viking in 2024.
Measles slows in some states. Reports on sexually transmitted shigellosis and flea-borne typhus.
RSV activity is declining nationally, but the season is running longer than usual.
Measles cases are past 1,500, vaccination rates are sliding, and a Hepatitis A outbreak in the Amalfi Coast region has health authorities banning raw seafood.
Measles cases top 1,487 with major outbreaks in four states. Plus clade I mpox in Missouri, a rare hantavirus case in New York, and a meningococcal outbreak in the UK.
Flu season is nearly over, but measles continues. RSV is peaking unusually late this year. A large-scale infant formula recall spans 99 countries.
NYC and Toronto report new clade I mpox cases linked to international travel, adding to a growing reports of clade Ib globally.
Flu is finally turning a corner, but measles continues to spread across more than 30 states, mumps activity is ticking up in Maryland, and two suspected hemorrhagic fever cases in DRC are worth knowing about before your patients ask.
Measles surges to 1,136 cases across 28 states; RSV rising; updates on legionellosis, Hansen's disease, and infant botulism.
Something worth watching is developing in flu data this week. Activity that looked like it was winding down may have more to go, and it's showing up in children.
Measles continues to spread across multiple states. Q fever cases flagged in California and Maryland. Varicella remains stable. New mumps cases reported.
📚 Does your institution provide access to professional resources? If you'd like institutional access, please recommend FOI Clinical to your librarian. Welcome to the second edition of FOI Clinical.
Early vaccine effectiveness estimates for flu, Covid-19, and RSV are in. Here's what clinicians need to know for patient counseling and late-season decision-making.